Skip to main content
OpenTrials
Completed

NCT Number: NCT04439474

Determining the Effect of Vitamin D, Dyslipidemia and Microvascular in Patients With Type 2 Diabetes

This study looked at the effect of vitamin D levels on the complications of type 2 diabetes and the fat profile of patients with diabetes.Participants in this study were divided into two groups. One group included participants with vitamin D deficiency and the other group did not.The first group receives 50,000 units of oral vitamin D 3 daily for up to 8 days.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Diabetes Mellitus, Type 2 Diabetes Mellitus Endocrine System Diseases Glucose Metabolism Disorders Metabolic Diseases Nutritional and Metabolic Diseases

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Mohammad Sadegh Bagheri Baghdasht

Tehran, Iran

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patients with type 2 diabetes
  • Having conscious satisfaction

Exclusion criteria

  • Patients with a history of gastrointestinal surgery
  • Patients with a history of renal failure
  • Patients with a history of vitamin D intake and calcium-containing compounds
  • Patients with a history of liver disease

Treatment and study plan

Vitamin D3

Drug

For up to 8 days, 50,000 units of vitamin D3 are given daily to patients in the first group so that the serum level of vitamin D reaches above 30 g / ml.

Routine Treatment

Drug

In this group, patients receive their usual medications and treatments

Primary outcomes

  1. Vitamin D serum levels

    Time frame: up to 1 year

    Vitamin D serum levels measured by blood tests

  2. Triglyceride

    Time frame: up to 1 year

    Level of blood triglycerides measured by a blood test

  3. Blood cholesterol levels

    Time frame: up to 1 year

    Blood cholesterol levels measured by a blood test

  4. HDL

    Time frame: up to 1 year

    Blood HDL levels measured by a blood test

  5. LDL

    Time frame: up to 1 year

    Blood LDL levels measured by a blood test

  6. Fasting blood glucose

    Time frame: up to 1 year

    Fasting blood glucose levels measured by a blood test

  7. Neuropathy

    Time frame: up to 1 year

    Neuropathy based on United Kingdom Screening TEST

  8. Nephropathy

    Time frame: up to 1 year

    Nephropathy based on albumin excretion evaluation

  9. Retinopathy

    Time frame: up to 1 year

    Retinopathy based on an ophthalmologist's examination

  10. blood pressure

    Time frame: up to 1 year

    Systolic and diastolic blood pressure measured by Sphygmomanometer

  11. HBA1C

    Time frame: up to 1 year

    Blood sugar levels measured in the last three months measured by blood test

Sponsors and collaborators

Lead sponsor

Baqiyatallah Medical Sciences University

Other

Registry information

Important dates

Study start
2018
Primary completion
2019
Study completion
2020
First posted
Jun 19, 2020
Registry last updated
Jun 19, 2020

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.